(L-R) Zhengyuan Jiang of the Blumberg Institute, Dr. Patrick Y. S. Lam and Steven Kultgen of Arbutus Biopharma. The Baruch S. Blumberg Institute presented the 2023 Lam Excellence in Medicinal Chemistry Award recently to Steven Kultgen of Arbutus Biopharma,
The collaboration will support the advancement of life sciences companies in Greater Philadelphia Hatch BioFund Management LLC (“Hatch BioFund”), an early- stage life sciences venture capital firm headquartered in the Philadelphia region, and Brandywine Realty Trust (“Brandywine”), one
Catharine and Rob Williams of Strafford are longtime supporters of the Foundation. The Hepatitis B Foundation announced today that Catharine and Rob Williams, who reside in Strafford, Pa., have been chosen to receive the Foundation’s Community Leadership
The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) honored Jim Greenwood, former Congressman and ex-CEO of BIO, at the organizations’ first Fireside Chat, held Oct. 17, by adding his portrait to their
Dr. Drew Weissman and Dr. Katalin Kariko The Baruch S. Blumberg Institute applauds Katalin Karikó, PhD, adjunct professor of Neurosurgery at The University of Pennsylvania’s Perelman School of Medicine, and Drew Weissman, MD, PhD, the Roberts Family
The National Institutes of Health Small Business Innovation Research (SBIR) Program has awarded a grant of more than $400,000 to researchers from Capital Health Cancer Center in Pennington, New Jersey, and JBS Scientific Inc. in Doylestown, Pennsylvania. The grant
Robert Christmas, a longtime bank executive in the Philadelphia area, has been named chief operating officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC). Louis P. Kassa III, chief executive officer of the three nonprofit organizations and president of the PABC, said: “Bob has
Collaboration will help attract talent, new capital and resources to region’s biomedical research pipeline. The Wistar Institute has formed a new strategic collaboration with the Pennsylvania Biotechnology Center (PABC) and the Baruch S. Blumberg Institute to accelerate the advancement of “bench to bedside”
MERLIN Biotech CEO Randall N. Hyer delivers details – and a comprehensive strategic plan – for the company’s promising mRNA technology MERLIN Biotech, a spinout from the Baruch S. Blumberg Institute, presented its first asset last month
By Damon Williams, Bucks County Courier Times Photo by Nur B. Adam, Bucks County Courier Times Timely state investment and cutting-edge laboratories and support has positioned the Doylestown-based Pennsylvania Biotechnology Center as crucial cog in Bucks County's
